Catalyst Wire Dossier Catalyst Wire Dossier

Ultra-high Dose Methylcobalamin

methylcobalamin · Eisai Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ultra-high Dose Methylcobalamin, covering 2025-03-26 to 2025-03-26. Get the full timeline:

Most recent: Clinical Trial Update: Clinical Trial of Ultra-high Dose Methylcobalamin for ALS [Phase 3]

See pricing